The founder of Hong Kong Cimuen., Ltd. inherited from the ancient Chinese medicine prescription of the Qing Dynasty. The Zhou family has practiced medicine for generations, and the ancient prescription is exquisite, saving countless sick people in the blink of an eye. It has been passed down for more than 300 years, and it has been passed down for several generations between generations. He is the director of Huitong Baijia medical book, and he has written the first ancient medical book. A famous Hong Kong medicine legend, it will not fall for a hundred years. The essence of herbs, the model is exquisite.
Up to now, Hong Kong Cimuen has developed into an international company with top technology and abundant capital. The headquarter of Cimuen Group has paid 200 million US dollars in registered capital, 12 million US dollars in food safety deposit for production lines, and holds 14 large international group companies. The company has two production bases: Hong Kong Kowloon production base and Australia New South Wales Hunter Valley production base of 1,500 mu. The strong production capacity is enough to provide consumers around the world with a steady stream of high-quality products.
All products of Hong Kong Cimuen are registered in the GS1 Hong Kong Article Numbering Center and can be traced globally. The company currently has 486 major series, 1486 products, and more than 5,000 gene-targeted drugs, including gene-targeted drugs, targeted purification skin care products, cosmetics, etc. It is also the world's only raw material supplier and manufacturer for high-end medical preparations , is an FDA-approved product. The company is also the only professional manufacturer of female products, the only clinical product in Europe and the United States, and the only product that has obtained European and American access. The representative ones include magnetic-controlled traditional Chinese medicine for breast enhancement, magnetic-controlled traditional Chinese medicine for menstruation regulation, etc., as well as high-end light luxury brands such as Cimuen, Ciyuan paste, six koalas, hundredtat, and bd. Ci Muen’s light luxury is valued at $75.0 billion, and Ciyuan paste is valued at $5.5 billion. The company's sales network covers Europe and the United States, Japan and South Korea, Southeast Asia, Australia and other regions, with annual sales reaching 300 billion US dollars.
The products produced by Hong Kong Cimuen are Hong Kong's external protective products, and it is the only Hong Kong Chinese medicine company that can print the Hong Kong Special Administrative Region Bauhinia badge on the product packaging, and is also the only Chinese medicine company that has clinical trials in Europe and the United States. Hong Kong Ci Muen has been in-depth cooperation with the Institute of Genetics of the National Academy of Sciences, the Hong Kong Sanatorium and Hospital, the Li Ka Shing School of Medicine of the University of Hong Kong, the Massachusetts General Hospital, and the Harvard Medical School, among which it has cooperated with the Li Ka Shing School of Medicine of the University of Hong Kong and developed the most advanced black enzyme Kaiping fermentation technology, leading the industry level, makes the product effect more efficient.